CYT Insider Trading Activity and SEC Form 4 Filings
CYT insider trading summary
No open-market insider purchases or sales of Cyteir Therapeutics, Inc. (CYT) have been reported on SEC Form 4 in the past 12 months.
Latest CYT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 20, 2024 | Braden Michael Leonard | Insider | Buy | $503K (170,589 @ $2.95) |
| Mar 18, 2024 | Braden Michael Leonard | Insider | Buy | $342K (113,777 @ $3.01) |
| Jul 20, 2023 | Novo Holdings A/S | 10% Owner | Sell | $275K (100,000 @ $2.75) |
| Jul 19, 2023 | Novo Holdings A/S | 10% Owner | Sell | $5K (1,900 @ $2.76) |
| Jul 18, 2023 | Novo Holdings A/S | 10% Owner | Sell | $18K (6,500 @ $2.76) |
| Jul 17, 2023 | Novo Holdings A/S | 10% Owner | Sell | $58K (21,100 @ $2.75) |
| Jul 14, 2023 | Novo Holdings A/S | 10% Owner | Sell | $30K (11,000 @ $2.74) |
| Jun 30, 2023 | Novo Holdings A/S | 10% Owner | Sell | $529K (200,937 @ $2.63) |
| Jun 27, 2023 | Novo Holdings A/S | 10% Owner | Sell | $57K (31,978 @ $1.77) |
| Jun 26, 2023 | Novo Holdings A/S | 10% Owner | Sell | $15K (8,437 @ $1.79) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.